Market Forecast By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines), By Animal Type (Livestock, Companion), By Route of Administration (Subcutaneous, Intramuscular, Intranasal) And Competitive Landscape
Product Code: ETC312455 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Report | |
Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Report Name | Australia Animal Vaccines Market |
Forecast period | 2025-2031 |
CAGR | 6.5% |
Growing Sector | Veterinary Hospitals |
The Australia Animal Vaccines market report thoroughly covers the market by product, by animal type, by route of administration and competitive Landscape. The report provides an unbiased and detailed analysis of the on-going market trends, opportunities/high growth areas, and market drivers which would help the stakeholders to devise and align their market strategies according to the current and future market dynamics.
The Australia animal vaccines market report offers a comprehensive analysis of the current state and future outlook of the animal vaccine industry in Australia. The report provides insights into key factors driving market growth such as increasing prevalence of animal diseases and advancements in vaccines technologies, as well as challenges and opportunities in the sector. However, the challenges faced by the animal vaccines market in Australia encompass various aspects such as vaccine shortages, regulatory hurdles for new vaccine approvals, the disruptive impact of the COVID-19 pandemic on veterinary care, intense competition among market players, and the evolving trends of pet humanization influencing consumer demands.
According to 6Wresearch, Australia Animal Vaccines market size is projected to grow at a CAGR of 6.5% during 2025-2031. The growth of the animal vaccines market in Australia is being driven by factors such as the increasing rate of pet adoption, rising expenditures on pet healthcare, advancements in veterinary medicine and technology, growing awareness about animal health, and an expanding focus on preventive care. These factors collectively contribute to a thriving market landscape, with a strong emphasis on ensuring the health and well-being of animals through the use of vaccines and preventive measures.
Government regulations play a crucial role in overseeing the animal vaccines market in Australia. The Australian Pesticides and Veterinary Medicines Authority (APVMA) is responsible for regulating and approving new veterinary vaccines in the country, ensuring compliance with stringent guidelines for manufacturers, both domestic and overseas. Further, these plans have improved the Australia Animal Vaccines Market Share. Additionally, the government mandates standards for the export of livestock, including companion animals, which impacts the use of vaccines in these animals for international trade.
The Key players in the animal vaccines market of Australia include Boehringer Ingelheim International GmbH, Zoetis Inc., Merck & Co. Inc., Virbac SA, Elanco, Bayer AG, Ceva Santé Animale, Hester Biosciences Limited, Phibro Animal Health Corporation, Biovac, Hipra, SEPPIC, SPI Pharma, Bioveta AS, Croda International PLC, KBNP, Nisseiken Co., Ltd., and Bioveta AS. Moreover, these firms hold enormous Australia Animal Vaccines Market Revenues. Further, these major players contribute significantly to the veterinary healthcare sector in Australia, driving innovation, research, and the availability of essential vaccines for animals.
The future insights of the animal vaccines market in Australia indicate promising growth prospects driven by various factors. The market is expected to witness advancements in biotechnology and vaccine development, leading to the introduction of novel vaccine platforms like recombinant vaccines and vectored vaccines that offer improved efficacy and safety profiles. Additionally, the shift towards proactive veterinary care, increased awareness among pet owners and livestock farmers about the importance of animal health, and the continuous progress in vaccine technology are expected to drive market growth.
According to Ravi Bhandari, Research Head, 6Wresearch, the companion animal vaccines market in Australia is expected to register significant growth during the forecast period. This can be attributed to factors such as increasing pet ownership, growing awareness about animal health and welfare, and rising disposable income among Australians.
Among the different Routes of administration for animal vaccines in Australia, the oral route is expected to register the highest growth rate. This can be attributed to various factors such as ease of administration and longer duration of immunity compared to other routes. However, subcutaneous and intramuscular routes are also widely used in the country due to their effectiveness and long-standing use in the market. Intranasal and intravenous routes, are still relatively new and are gradually gaining acceptance among veterinarians and pet owners.
Among various product segments, the live attenuated vaccine segment is anticipated to witness significant growth. Live attenuated vaccines are prepared from living microorganisms that have been weakened or modified in laboratory conditions. These vaccines provide long-term immunity and are highly effective in preventing diseases such as rabies, parvovirus, and feline leukemia. They also have the advantage of being cost-effective and easy to administer.
The Australia Animal Vaccines market report provides a detailed analysis of the following market segments:
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Animal Vaccines Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Animal Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Animal Vaccines Market - Industry Life Cycle |
3.4 Australia Animal Vaccines Market - Porter's Five Forces |
3.5 Australia Animal Vaccines Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Australia Animal Vaccines Market Revenues & Volume Share, By Animal Type, 2021 & 2031F |
3.7 Australia Animal Vaccines Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 Australia Animal Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about animal health and welfare |
4.2.2 Rising prevalence of animal diseases |
4.2.3 Government initiatives to promote vaccination in animals |
4.3 Market Restraints |
4.3.1 High cost associated with vaccine development and production |
4.3.2 Stringent regulatory requirements for vaccine approval |
4.3.3 Limited availability of skilled professionals in the veterinary sector |
5 Australia Animal Vaccines Market Trends |
6 Australia Animal Vaccines Market, By Types |
6.1 Australia Animal Vaccines Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Australia Animal Vaccines Market Revenues & Volume, By Product, 2021-2031F |
6.1.3 Australia Animal Vaccines Market Revenues & Volume, By Attenuated Live Vaccines, 2021-2031F |
6.1.4 Australia Animal Vaccines Market Revenues & Volume, By Inactivated Vaccines, 2021-2031F |
6.1.5 Australia Animal Vaccines Market Revenues & Volume, By Subunit Vaccines, 2021-2031F |
6.1.6 Australia Animal Vaccines Market Revenues & Volume, By DNA Vaccines, 2021-2031F |
6.1.7 Australia Animal Vaccines Market Revenues & Volume, By Recombinant Vaccines, 2021-2031F |
6.2 Australia Animal Vaccines Market, By Animal Type |
6.2.1 Overview and Analysis |
6.2.2 Australia Animal Vaccines Market Revenues & Volume, By Livestock, 2021-2031F |
6.2.3 Australia Animal Vaccines Market Revenues & Volume, By Companion, 2021-2031F |
6.3 Australia Animal Vaccines Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Australia Animal Vaccines Market Revenues & Volume, By Subcutaneous, 2021-2031F |
6.3.3 Australia Animal Vaccines Market Revenues & Volume, By Intramuscular, 2021-2031F |
6.3.4 Australia Animal Vaccines Market Revenues & Volume, By Intranasal, 2021-2031F |
7 Australia Animal Vaccines Market Import-Export Trade Statistics |
7.1 Australia Animal Vaccines Market Export to Major Countries |
7.2 Australia Animal Vaccines Market Imports from Major Countries |
8 Australia Animal Vaccines Market Key Performance Indicators |
8.1 Percentage increase in vaccination coverage among different animal species |
8.2 Number of research and development partnerships in the animal vaccine industry |
8.3 Adoption rate of new and advanced animal vaccines |
8.4 Average time taken for regulatory approval of animal vaccines |
8.5 Number of veterinary professionals trained in administering vaccines |
9 Australia Animal Vaccines Market - Opportunity Assessment |
9.1 Australia Animal Vaccines Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Australia Animal Vaccines Market Opportunity Assessment, By Animal Type, 2021 & 2031F |
9.3 Australia Animal Vaccines Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10 Australia Animal Vaccines Market - Competitive Landscape |
10.1 Australia Animal Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Australia Animal Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |